SG11201810606TA - FUSION PROTEIN FOR IMPROVING PROTEIN EXPRESSION FROM TARGET mRNA - Google Patents
FUSION PROTEIN FOR IMPROVING PROTEIN EXPRESSION FROM TARGET mRNAInfo
- Publication number
- SG11201810606TA SG11201810606TA SG11201810606TA SG11201810606TA SG11201810606TA SG 11201810606T A SG11201810606T A SG 11201810606TA SG 11201810606T A SG11201810606T A SG 11201810606TA SG 11201810606T A SG11201810606T A SG 11201810606TA SG 11201810606T A SG11201810606T A SG 11201810606TA
- Authority
- SG
- Singapore
- Prior art keywords
- protein
- target mrna
- fusion protein
- improving
- protein expression
- Prior art date
Links
- 108020004999 messenger RNA Proteins 0.000 title abstract 3
- 108020001507 fusion proteins Proteins 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 3
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662345252P | 2016-06-03 | 2016-06-03 | |
| JP2016120524 | 2016-06-17 | ||
| PCT/JP2017/020076 WO2017209122A1 (ja) | 2016-06-03 | 2017-05-30 | 標的ｍＲＮＡからのタンパク質発現量を向上させるための融合タンパク質 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810606TA true SG11201810606TA (en) | 2018-12-28 |
Family
ID=60478518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810606TA SG11201810606TA (en) | 2016-06-03 | 2017-05-30 | FUSION PROTEIN FOR IMPROVING PROTEIN EXPRESSION FROM TARGET mRNA |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR102407776B1 (ko) |
| AU (1) | AU2017275184B2 (ko) |
| CA (1) | CA3026340A1 (ko) |
| SG (1) | SG11201810606TA (ko) |
| WO (1) | WO2017209122A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114729017A (zh) | 2019-05-29 | 2022-07-08 | 日商基因编辑力股份有限公司 | Ppr蛋白的有效制作方法及其应用 |
| BR112021023937A2 (pt) | 2019-05-29 | 2022-04-19 | Editforce Inc | Motivo ppr, uso do motivo ppr, proteína capaz de se ligar a um ácido nucleico alvo, proteína de fusão, métodos para modificar uma proteína ppr contendo o motivo ppr, para manipular um ácido nucleico, para detectar um ácido nucleico e para produzir um organismo, ácido nucleico, vetor, e, célula |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4665190B2 (ja) * | 2005-02-10 | 2011-04-06 | 学校法人東京理科大学 | 遺伝子の転写調節方法 |
| WO2008009727A1 (en) * | 2006-07-21 | 2008-01-24 | Centre National De La Recherche Scientifique (Cnrs) | Positive cytomodulines to improve bioreactor productivity. |
| JP2013128413A (ja) * | 2010-03-11 | 2013-07-04 | Kyushu Univ | Ｐｐｒモチーフを利用したｒｎａ結合性蛋白質の改変方法 |
| ES2751126T3 (es) * | 2011-10-21 | 2020-03-30 | Univ Kyushu Nat Univ Corp | Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo |
| NZ752705A (en) * | 2013-04-22 | 2023-01-27 | Univ Kyushu Nat Univ Corp | Dna-binding protein using ppr motif, and use thereof |
| JP2015221026A (ja) * | 2014-05-23 | 2015-12-10 | 公立大学法人名古屋市立大学 | 人工合成ｍＲＮＡの翻訳効率化方法 |
-
2017
- 2017-05-30 CA CA3026340A patent/CA3026340A1/en active Pending
- 2017-05-30 AU AU2017275184A patent/AU2017275184B2/en active Active
- 2017-05-30 WO PCT/JP2017/020076 patent/WO2017209122A1/ja unknown
- 2017-05-30 KR KR1020187037821A patent/KR102407776B1/ko active IP Right Grant
- 2017-05-30 SG SG11201810606TA patent/SG11201810606TA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017209122A1 (ja) | 2017-12-07 |
| AU2017275184B2 (en) | 2021-05-06 |
| KR20190015374A (ko) | 2019-02-13 |
| KR102407776B1 (ko) | 2022-06-10 |
| CA3026340A1 (en) | 2017-12-07 |
| AU2017275184A1 (en) | 2018-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501656A1 (en) | Methods for using fxr agonists | |
| EP4265261A3 (en) | Methods and compositions for inhibiting expression of ldha | |
| PH12019502724A1 (en) | Compositions for modulating c9orf72 expression | |
| IL254403A0 (en) | Methods for lowering the amount of fc-containing substances in the serum by using fcrn antibodies | |
| MX2020007166A (es) | Composiciones para modular la expresion de sod-1. | |
| MX2017004806A (es) | Pestañasde aplicacion heterogeneas. | |
| EA201391572A1 (ru) | Модулирование экспрессии вируса гепатита в (hbv) | |
| MA42135A (fr) | Méthodes et trousses pour traiter la dépression | |
| MX2018000590A (es) | Moleculas de anticuerpo que se unen a agrupacion de diferenciacion 79 (cd79). | |
| MX2018016057A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| PH12016500158A1 (en) | Methods for controlling fucosylation levels in proteins | |
| MX2018011875A (es) | Reprogramacion cardiaca directa mejorada. | |
| EP3649240A4 (en) | RNAI ALPHA-ENaC GENE EXPRESSION INHIBITION AGENTS AND METHODS OF USE | |
| SG11201810606TA (en) | FUSION PROTEIN FOR IMPROVING PROTEIN EXPRESSION FROM TARGET mRNA | |
| NZ731491A (en) | Cd83 binding proteins and uses thereof | |
| EP3298139A4 (en) | PROCESS FOR PREVENTING OR INACTIVATING VIRAL AND MICROBIAL CONTENT IN THE METHOD FOR PRODUCING PANCREATINE | |
| WO2019022586A3 (ko) | 간암의 예방 또는 치료용 약학적 조성물 | |
| DK3577237T3 (da) | Fremgangsmåde til indikation af en tilstedeværelse eller ikke-tilstedeværelse af prostatacancer hos individer med bestemte karakteristika | |
| EP4400600A3 (en) | Methods for detecting multiple nucleic acids in a sample | |
| MX2018011193A (es) | Proteinas derivadas de alfa-1-microglobulina novedosas y su uso. | |
| EP3268011A4 (en) | INHIBITORS OF THE DEK PROTEIN AND RELATED METHODS | |
| EP3399058A4 (en) | Method for refining magnetic domain of grain-oriented electrical steel sheet, and device therefor | |
| GB201416728D0 (en) | Aparatus for determining identity and/or quantity of a fuel | |
| EP3677679A4 (en) | ARNSI MOLECULE INHIBITING PCSK9 GENE EXPRESSION AND ITS APPLICATION | |
| EP4077691A4 (en) | METHODS FOR ENHANCING AND ACCELERATING ANTIBODY EXPRESSION |